Cell experiment results showed that Cynarine could reduce the fat deposition ability of NAFLD model cells, and effectively reduce the levels of ALT and AST released by liver cells due to excessive lipid accumulation. This evidence concerns the gene GPT and metabolic dysfunction-associated steatotic liver disease.